Maverick Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-115,895
Closed -$1.09M 819
2020
Q3
$1.09M Sell
115,895
-51,647
-31% -$491K 0.02% 268
2020
Q2
$1.28M Buy
+167,542
New +$1.28M 0.03% 263

Maverick Capital's AMAG Position: Q4 2020 in Review

Maverick Capital sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 115,895 shares — an estimated $1.09M sold.

Maverick Capital first reported a position in AMAG in Q2 2020 and held it in 2 quarters. The position peaked at $1.28M in Q2 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Maverick Capital reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Maverick Capital sold 115,895 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.09M.
  • Maverick Capital first reported a position in AMAG Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Maverick Capital's AMAG Pharmaceuticals position peaked at $1.28M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Maverick Capital's 13F filing for Q4 2020, filed 16 Feb 2021.